Collegeville, PA, United States of America

Attiq Rahman

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Attiq Rahman. Retrieved from https://idiyas.com/inventor/attiq-rahman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Attiq Rahman: Pioneering Innovations in Collegeville

Introduction: Attiq Rahman is a visionary inventor based in Collegeville, PA, known for his groundbreaking contributions to various fields.

Latest Patents: Attiq Rahman's latest patents include cutting-edge technologies in renewable energy, healthcare devices, and artificial intelligence systems.

Career Highlights: With a career spanning over two decades, Attiq Rahman has established himself as a leading figure in the innovation landscape, with numerous successful inventions and patents to his name.

Collaborations: Attiq Rahman has collaborated with top research institutions, universities, and companies worldwide to bring his innovative ideas to life, showcasing his ability to work across diverse teams and disciplines.

Conclusion: Attiq Rahman's passion for pushing the boundaries of technology and his relentless drive for innovation continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…